JPS6110590A - ジアザテトラシクロ化合物を含有する抗腫瘍剤 - Google Patents

ジアザテトラシクロ化合物を含有する抗腫瘍剤

Info

Publication number
JPS6110590A
JPS6110590A JP60140084A JP14008485A JPS6110590A JP S6110590 A JPS6110590 A JP S6110590A JP 60140084 A JP60140084 A JP 60140084A JP 14008485 A JP14008485 A JP 14008485A JP S6110590 A JPS6110590 A JP S6110590A
Authority
JP
Japan
Prior art keywords
formula
salt
compound
tables
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60140084A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0152368B2 (enExample
Inventor
Masanobu Kosaka
向阪 正信
Hiroshi Terano
寺野 紘
Morita Ishimi
小森 忠昭
Michio Yamashita
盛太 石見
Shinji Hashimoto
道雄 山下
Itsuro Uchida
眞志 橋本
Shigehiro Takase
内田 逸郎
茂弘 高瀬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS6110590A publication Critical patent/JPS6110590A/ja
Publication of JPH0152368B2 publication Critical patent/JPH0152368B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP60140084A 1984-06-25 1985-06-25 ジアザテトラシクロ化合物を含有する抗腫瘍剤 Granted JPS6110590A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8416141 1984-06-25
GB848416141A GB8416141D0 (en) 1984-06-25 1984-06-25 Fr-900482 substance
GB8510378 1985-04-24

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP63-325492A Division JPH078872B2 (ja) 1984-06-25 1985-06-25 新規なテトラシクロ化合物およびその製造法

Publications (2)

Publication Number Publication Date
JPS6110590A true JPS6110590A (ja) 1986-01-18
JPH0152368B2 JPH0152368B2 (enExample) 1989-11-08

Family

ID=10562947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60140084A Granted JPS6110590A (ja) 1984-06-25 1985-06-25 ジアザテトラシクロ化合物を含有する抗腫瘍剤

Country Status (4)

Country Link
US (1) US4861774A (enExample)
JP (1) JPS6110590A (enExample)
GB (1) GB8416141D0 (enExample)
ZA (1) ZA854469B (enExample)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB974168A (en) * 1961-06-26 1964-11-04 Ici Ltd Manufacture of 2-ª‰-methoxyethylpyridine

Also Published As

Publication number Publication date
GB8416141D0 (en) 1984-08-01
ZA854469B (en) 1986-02-26
US4861774A (en) 1989-08-29
JPH0152368B2 (enExample) 1989-11-08

Similar Documents

Publication Publication Date Title
JPH0764872B2 (ja) Fr901228物質およびその製造法
US5541181A (en) Compound produced by a strain of micromonospora
KR940000759B1 (ko) 신규 글리코펩티드계 항생물질의 제조방법
EP0926242A1 (en) Gliotoxin derivatives and anticancer agent comprising the same
HUT70524A (en) Novel makrolides and their use
DK170892B1 (da) 14-Oxa-1,11-diazatetracyclo[7.4.1.02,7.010,12]tetra-deca-2,4,6-trien-forbindelser, fremgangsmåde til fremstilling heraf, farmaceutiske præparater der indeholder forbindelserne samt anvendelse af forbindelserne til fremstilling af lægemidler og en kultur af mikroorganismen Streptomyces sandaensis
JPH0521909B2 (enExample)
KR100229257B1 (ko) 폴리히드록시시클로펜탄 유도체, 그의 제조방법 및 그의 치료적 용도
US4863955A (en) Scytophycins
US5128370A (en) Furans and lactones from sterptomycetes and the use thereof
RU2285008C2 (ru) Новые полициклические ксантоны и их применение
JPS6110590A (ja) ジアザテトラシクロ化合物を含有する抗腫瘍剤
RU2221870C2 (ru) Мумбайстатин, способ его получения и его применение в качестве фармацевтического препарата
JPWO1997011947A1 (ja) 抗ウイルス活性を有するセスキテルペン誘導体
US5334613A (en) Antibacterial substance BE-24566B
JP2862986B2 (ja) ジテルペン化合物およびその製造法
KR100225458B1 (ko) 믹소코크스 속의 점액세균, 이로부터 생산되는 신규 항종양활성 화합물 및 그의 제조방법
US5252472A (en) Process for the production of furans and lactones from streptomyces
JP2786267B2 (ja) 新規物質dc116
JP3773310B2 (ja) Uck14化合物
JPH1017527A (ja) 抗菌性物質be−39589類及びその製造法
MXPA00011165A (es) Mumbaistatin, un proceso para su produccion y su empleo como un producto farmaceutico
JPH08208644A (ja) 新規抗生物質クレミマイシンとその製造法及び用途
JPH09100261A (ja) 抗菌性物質be−44651類
JPH07291955A (ja) 新規抗生物質n1999a2